Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PKLR | P30613 | 6/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6572882 | 0.86 | MEN1 (0.52) | MEN1KMT2AALDH1A1MAPTNPSR1 | |
| SCHEMBL6771025 | 0.80 | F2 (0.55) | F2KMT2AALDH1A1PRSS1PRSS2 | |
| SCHEMBL6766786 | 0.80 | F2 (0.60) | F2ALDH1A1PRSS1PRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL7358299 | 0.76 | F2 (0.63) | F2MEN1KMT2AALDH1A1ST14 | |
| SCHEMBL6771137 | 0.76 | F2 (0.62) | F2PRSS1PRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL6636092 | 0.75 | F2 (0.56) | F2PKMPKLR | |
| Hydrochloric Acid SCHEMBL8031426 | 0.75 | F2 (0.65) | F2MEN1KMT2AALDH1A1ST14 | |
| SCHEMBL2690153 | 0.75 | MEN1 (0.66) | MEN1KMT2AALDH1A1TP53GAA | |
| Hydrochloric Acid SCHEMBL8016170 | 0.75 | F2 (0.63) | F2MEN1KMT2AALDH1A1ST14 | |
| Hydrochloric Acid SCHEMBL8026588 | 0.74 | F2 (0.74) | F2MEN1KMT2AALDH1A1ST14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040248897-A1 | Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248897-A1 | Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions | NAT1, CYP3A5, CYP3A7 | F2 612/4885MEN1 1875/4885KMT2A 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.